Discovery UK: In-Person

: Speakers

Speakers

26 - 27 October 2021 | London, UK

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 event.

Alexander Hillisch

Vice President, Head of Computational Molecular Design

Bayer AG

Barbara Calamini

Principal Scientist Group Leader - Cell Biology

Sanofi

Bart Lenselink

Senior Scientist, Computational Chemistry

Galapagos

Ben-Fillippo Krippendorff

DMPK/PD Project Leader Pharmaceutical Sciences

Roche Pharma Research & Early Development

Brandon Allgood

Senior Vice President, Data Science & AI

Integral Health

Carl Petersson

Scientific Director Drug Disposition

Merck KGaA

Cecile Geuijen

Vice President Oncology, Cell Biology

Merus

Dale Starkie

Senior Scientist

UCB

David Evans

Chief Scientific Officer

Sirnaomics, Inc

Davide Gianni

Director, Functional Genomics, Discovery Biology

AstraZeneca

Eric Fischer

Associate Professor of Biological Chemistry and Molecular Pharmacology, Co-Director DFCI Center for Protein Degradation, Dana-Farber Cancer Institute

Harvard Medical School

Frank Mercurio

Chief Scientific Officer

BioTheryX, Inc.

Friedrich Rippmann

Director, Computational Chemistry & Biology, Global Research & Development, Discovery & Development Technologies

Merck Healthcare KGaA

Gennaro Pagano

Expert Medical Director, Group Leader in Early Development, Chair of Medical Directors Fellowship

Roche

Gianni Chessari

Vice President, Head of Medicinal Chemistry

Astex Pharmaceuticals

Gregory Vladimer

Chief Scientific Officer

Allcyte

Hans-Juergen Volkmer

Professor

NMI

Hasane Ratni

Expert Scientist

F. Hoffmann-La Roche Ltd

Ian Churcher

Chief Scientific Officer

Amphista Therapeutics Limited

Ian Storer

Director

AstraZeneca

Iolanda Micco

Associate Director, Chemistry And Alliances

Vipergen ApS

Istvan Enyedy

Director Computational Chemistry

Black Diamond Therapeutics

Jadwiga Bienkowska

Senior Director, Head of Computational Biology Oncology R&D

Pfizer

Jake Wiener

Senior Director, Medicinal Chemistry

Lundbeck

Jessica Alexander

Principal Scientist, Biology

Lundbeck

John Delaney

Director, Research

Amgen

Jörg Bentzien

Research Fellow, Discovery

Alkermes, Inc.

Justin Hall

Principal Scientist

Pfizer

Laura Rosenberg

Associate Director Target Validation

AstraZeneca

Lewis Vidler

Principal scientist CADD

UCB

Madhurima Benekareddy

Madhurima Benekareddy, Project Leader, Hoffmann-La Roche, Basel

F. Hoffmann-La Roche Ltd

Miriam Ramos

Team Leader Computational Chemistry

Galapagos

Nils Weskamp

Team Leader Computational Chemistry,

Boehringer Ingelheim

Paul Richardson

Director Discovery Chemistry

Pfizer

Phil Cox

Research Fellow, Head of Augmented Molecular Design, Drug Discovery Science and Technology

AbbVie

Pieter Fokko van Loo

Director Oncology Immunology

Merus

Richard Lewis

Global Head CADD

Novartis

Rob Howes

Director Discovery Biology

AstraZeneca

Rolf Jautelat

Vice President Medicinal Chemistry

Bayer AG

Ryan Potts

Executive Director & Head of Induced Proximity Platform

Amgen

Sandra Stefanovic-Barrett

Senior Research Scientist,Discovery Biology, Discovery SciencesCellular Assay Development

AstraZeneca

Stefan Schiesser

Senior Scientist

AstraZeneca

Stephanos Ioannidis

Vice President, Head of Chemistry

H3 Biomedicine

Stephen Pickett

Scientific Director & GSK Fellow

GlaxoSmithKline

Tauseef Butt

President and Chief Executive Officer

Progenra Inc

Thierry Dorval

HCS - Group Leader, Biotechnology Chemical-Biology

Servier Monde

Torsten Hoffmann

Global R&D Director

Oryzon Genomics

Vivek Vishnudas

Senior Vice President Drug Discovery and Platform Sciences

BERG Health

Werngard Czechtizky

Senior Director, Head Medicinal Chemistry, IMED RIA

AstraZeneca

Xavier Jacq

Vice President Biology

Almac Discovery Ltd

Yue Xiong

Chief Scientific Officer

Cullgen